MondayApr 10, 2017 9:13 am

InMed Pharmaceuticals, Inc. (IMLFF) Offers More than Just a Non-THC Cannabinoid Drug Pipeline

Now that 28 states have passed comprehensive medical marijuana laws, conditions have never looked better for expanding research and development (R&D) into the therapeutic benefits of cannabinoids, which is exactly what InMed Pharmaceuticals, Inc. (CSE: IN) (OTCQB: IMLFF) is doing. Its efforts have already borne results: the company has two novel drug candidates in its pipeline. But there’s more to InMed than meets the eye; the Vancouver, Canada-based company has developed a proprietary process to manufacture cannabinoids based on biosynthesis. In addition, it has constructed an algorithm to identify the cannabinoids most likely to have beneficial therapeutic effect. With this…

Continue Reading

FridayApr 07, 2017 12:28 pm

Player’s Network, Inc. (PNTV) – Using Unique Business Models to Increase Revenue

Player’s Network, Inc. (OTCQB: PNTV) is a fully reporting diversified holdings company, operating in two main industries: medical marijuana and media. The company’s primary objective is to create shareholder value by identifying opportunities in niche emerging markets. PNTV has three prominent subsidiaries: Next Gen TV, WeedTV.com, and Green Leaf Farms, all of which operate under profitable business models. The primary goal for WeedTV.com is to generate revenues from its proprietary channels and clients. Proprietary channels that Player’s Network is able to generate revenues through include membership subscriptions, advertising, and cross-selling with other organizations. In addition to this, the company’s Next…

Continue Reading

FridayApr 07, 2017 9:21 am

India Globalization Capital, Inc. (NYSE: IGC) at the Forefront of Innovation Thanks to Strategic Alliances

How does a company in the mining industry successfully move toward becoming a leader in the marijuana sector, specifically cannabinoid-based pharmaceutical therapies that treat a variety of diseases and conditions? In the case of India Globalization Capital, Inc. (NYSE MKT: IGC), the answer is creative management’s ability to identify opportunity, coupled with a relentless drive toward innovation. IGC made its switch to the marijuana industry after its CEO, Executive Chairman, and President Ram Mukunda was unafraid to recognize and act on a need for the company to make a positive and swift switch to a stronger and more lucrative market.…

Continue Reading

ThursdayApr 06, 2017 1:01 pm

InMed Pharmaceuticals, Inc. (IMLFF) Adds to Its Drug Development Pipeline

A pre-clinical stage biopharmaceutical company, InMed Pharmaceuticals, Inc. (OTCQB: IMLFF) has revealed two additions to its drug development pipeline. An expedited drug development timeline is now in place for INM-750 for epidermolysis bullosa (EB), with a potential market of about $1 billion. The disease is characterized by fragile skin in children. The company has also announced the development of INM-085 for glaucoma, which represents a potential global market of over $5 billion. Resulting in a defect in the connective tissue between the dermis and epidermis, most often caused by a lack of keratins, EB currently has no medication-based treatments. Multiple…

Continue Reading

ThursdayApr 06, 2017 11:33 am

SinglePoint, Inc. (SING) Set to Capitalize on Congressional Push to Regulate and Tax Marijuana

The U.S. Congress in March introduced legislation to regulate and tax marijuana and to remove it from the federal Controlled Substances Act. The move (http://nnw.fm/Qi81t) would effectively end cannabis prohibition and allow it to be regulated in a way alcohol has been since 1933. This move would be highly beneficial for SinglePoint, Inc. (OTC: SING), a leading mobile technology and payment solutions company that provides ancillary services to the marijuana industry. Legislation was introduced by Sen. Ron Wyden (D-OR) and Rep. Jared Polis (D-CO). It would allow the states to choose to legalize cannabis at their discretion. Also, federal regulations…

Continue Reading

WednesdayApr 05, 2017 3:30 pm

ChineseInvestors.com, Inc. (CIIX) Combating Alzheimer’s Disease through Development of CBD Health Products

China’s growing economy has proven to be beneficial to many across the country. Some of these benefits include higher living standards, better health and nutrition, and longer life expectancy. Unfortunately, China’s longer-lived population has resulted in a significant increase in the number of people having to care for seniors with various mental dysfunctions, most notably dementia and, in particular, Alzheimer’s disease. Alzheimer’s is a neurodegenerative type of dementia that is most prominent in elderly people. The disease is a disorder that involves the death of brain cells leading to various cases of memory loss and cognitive decline. The disease starts…

Continue Reading

WednesdayApr 05, 2017 8:30 am

Marijuana Market Offers Variety of Investment Options and Consistent, Long-Lasting Growth Potential

With the North American cannabis market boasting an estimated worth of $7.2 billion in 2016, and new reports projecting CAGR of between 17 percent and 25 percent within the next few years, it's certainly an exciting time to invest in the marijuana market. Investment opportunities are abundant and diverse with companies like SinglePoint, Inc. (SING) (SING Profile), Innovative Industrial Properties Inc. (IIPR), Insys Therapeutics Inc. (INSY), MassRoots Inc. (MSRT) and Axim Biotechnologies Inc. (AXIM). The marijuana market is on fire for more reasons than one. First, there's the huge potential for financial growth. A recent report from New Frontier Data…

Continue Reading

FridayMar 31, 2017 3:27 pm

India Globalization Capital, Inc. (NYSE: IGC) From Mining to Marijuana

At first blush, India Globalization Capital (NYSE: IGC) would seem a curiosity clothed in an enigma. Just how does a NYSE company move from a successful mining orientation to a pioneer in the development of multiple cannabinoid-based pharmaceutical therapies to treat pain and disease? The enigma can be disrobed by looking at the tenacity and vision of its management. Ram Mukunda has served as Executive Chairman, CEO and President of India Global since inception in 2005. He holds distinguished mathematics and engineering degrees and worked in multiple Wall Street positions for more than 25 years, serving communications firms such as…

Continue Reading

ThursdayMar 30, 2017 12:37 pm

Singlepoint, Inc. (SING) Interview Reveals How the Cannabis Industry is Incorporating Technology

The legalization of cannabis across many states in the U.S. has opened doors to various innovators, leaving the tech world to rapidly adapt to this trending industry. There’s now a strong move by cannabis-oriented businesses to incorporate common technologies found in other industries, and such innovations are not just found in dispensaries. Improvements are being made on the technology surrounding the agricultural, marketing, production, and distribution channels in the marijuana market. Technology is also being used to solve challenging issues such as payment options. Singlepoint, Inc. (OTC: SING), a publicly traded holding company, offers payment solutions to the cannabis industry…

Continue Reading

ThursdayMar 30, 2017 8:30 am

Pain-Reducing Combination Therapies Proving Successful thanks to Innovative, Specialty Pharma Players

Combination therapies that use cannabis-based pain reduction methods without the negative side effects of opioids are looking to be a positive growth opportunity among specialty pharmaceuticals, particularly for postoperative and chronic pain relief. Leading specialty pharma companies such as India Globalization Capital, Inc. (NYSE: IGC) (IGC Profile), Cara Therapeutics, Inc. (NASDAQ: CARA), Zynerba Pharmaceuticals, Inc. (NASDAQ: ZYNE), and INSYS Therapeutics, Inc. (NASDAQ: INSY) are tirelessly working to expand combination therapeutics product lines, while Pacira Pharmaceuticals, Inc. (NASDAQ: PCRX) developing an opioid alternative drug intended to reduce pain after surgery. To date, it is estimated that the annual national cost of…

Continue Reading

HempWire Currently Accepts

Bitcoin

Bitcoin

Bitcoin Cash

Bitcoin Cash

Doge Coin

Dogecoin

Ethereum

Ethereum

Litecoin

Litecoin

USD Coin

USD Coin

Contact us: 303.498.7722